europsychiatric and Neurocognitive Burden in Patients withpreviously treated Pituitary Adenomas
Not Applicable
- Conditions
- Health Condition 1: D3A8- Other benign neuroendocrine tumors
- Registration Number
- CTRI/2019/11/021962
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age >18 years
2. The patient should be on active follow up
3. May have available dosimetric data from the treatment planning system.
4. Should consent for assessment thrice (0, 1 and 2 years).
Exclusion Criteria
Exclude patients from Ongoing shape study (IEC approved; 1630)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study will <br/ ><br>help in understanding the burden of neurocognitive, neuropsychiatric and quality of life issues in these long <br/ ><br>term survivors and their needs.Timepoint: Post radiotherapy atleast 6mnth. On F/U yearly assessment for 2 yrs per patient. <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. Neurocognitive and neuropsychiatric function change in patient over 1 year time <br/ ><br>2. Impact of previous treatment and type on Neurocognitive and neuropsychiatric function <br/ ><br>3. impact of type of radiation treatment on Neurocognitive and neuropsychiatric function <br/ ><br>4. Neurocognitive and neuropsychiatric function at different time points on follow upsTimepoint: Post radiotherapy atleast 6mnth. On F/U yearly assessment for 2 yrs per patient.